|
| |
| | | 66339 | | 19.09.2017 | | Mepha Pharma AG | | | | | | | | | | | | | 80000. | | | | 08.03. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Atazanavir-Mepha 150 mg | Hartkapseln | Capsules (Atazanavir 150 mg) | J05AE08 | CI | | 02 | Atazanavir-Mepha 200 mg | Hartkapseln | Capsules (Atazanavir 200 mg) | J05AE08 | CI | | 03 | Atazanavir-Mepha 300 mg | Hartkapseln | Capsules (Atazanavir 300 mg) | J05AE08 | CI |
|
|
|
